Ticker

No recent analyst price targets found for PMEDF.

Latest News for PMEDF

QScreen AI Launches European Investor Roadshow Following Recent Strategic and Technology Milestones

Toronto, Ontario--(Newsfile Corp. - June 1, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announced that members of its senior leadership team will participate in a five-city investor roadshow across Central Europe from June 1 to June 5, 2026. Date City       June 1 Munich, Germany       June 2 Ljubljana, Slovenia       June 3…

Newsfile Corp • Jun 1, 2026
QScreen AI Appoints Former Pentagon Joint Artificial Intelligence Center Director Lt. Gen. Michael S.

Former US Department of Defense AI leader joins QScreen AI after reviewing the platform in person to support institutional commercialization efforts across North America Toronto, Ontario--(Newsfile Corp. - May 19, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen" or "QAI"), an innovator in physiological AI screening, today announces the appointment of Lieutenant General Michael S. Groen (Ret.

Newsfile Corp • May 19, 2026
QScreen AI Integrates Passive Voice Analysis into Multi-Signal Screening Platform - System Now Reads Physiological, Acoustic, and Behavioral Signals Simultaneously in Real Time

Individual voice baseline established on first encounter, deviation measured on every return visit; no additional hardware required; platform now fully integrated across all three signal modalities Toronto, Ontario--(Newsfile Corp. - May 6, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP) ("QScreen"), today announced the full integration of a novel voice analysis engine into its multi-signal screening…

Newsfile Corp • May 6, 2026
QScreen AI Reports Internal Validation Results for Correctional Intake Platform: 100% Sensitivity on Suicide Risk and Withdrawal Detection Across 65 Calibrated Clinical Scenarios

Nine instruments validated against published standards including Columbia C-SSRS, CIWA-Ar, and COWS; paper-only workflow showed materially lower detection rates across the same scenarios; 60-day live pilot structured and ready Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to transform health screening today…

Newsfile Corp • May 4, 2026
QScreen AI Appoints Former Union Pacific Vice President as Strategic Advisor to Drive Expansion into North American Rail and Transportation Markets

Veteran rail executive with 25 years of senior commercial relationships across North America's Class I railroads joins a platform that enables real-time identification of probable drug use from a camera without requiring blood, breath, or urine testing. Toronto, Ontario--(Newsfile Corp. - April 29, 2026) - QScreen AI Inc. (CSE: QAI) (OTC Pink: PMEDF) (FSE: 3QP), an innovator fusing Quantum-AI technologies to…

Newsfile Corp • Apr 29, 2026

🧮 Earnings Move Analyzer

Insider Trading

No insider trades found for PMEDF.

No Senate trades found for PMEDF.

No House trades found for PMEDF.

Options Chain

Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.

Scroll to Top